微信内可能无法直接打开本站。请点右上角 ··· → 在浏览器打开，或复制链接。
STAT+: After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026
RSS 官方收录 · 可信分层展示
关键摘要
The number of people working in Massachusetts’ renowned biotech sector fell last year, the first time that’s happened since at least 2002, according to a new report.…
- The state’s biopharma workforce shrank by about 3,600 employees in 202…
- Compared to 2024, the workforce declined by 3.
- Many of the lab buildings in Greater Boston that everyone thought woul…
摘要引擎：抽取
正文提要
The number of people working in Massachusetts’ renowned biotech sector fell last year, the first time that’s happened since at least 2002, according to a new report.
The state’s biopharma workforce shrank by about 3,600 employees in 2025, to a total of 113,503, as industry headwinds and uncertainty about federal funding for scientific research battered the sector, according to the annual “industry snapshot” by the Massachusetts Biotechnology Council trade group. Compared to 2024, the workforce declined by 3.1%.
Many of the lab buildings in Greater Boston that everyone thought would be filled with scientists when venture capital flowed freely early in the pandemic now stand empty, a symbol of what former Federal Reserve chairman Alan Greenspan once dubbed irrational exuberance.